AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients
ABBVIE INC. · PHARMACEUTICAL PREPARATIONS · Now $217.72
+1.9% in 7d after detection
Post-detection moves
1h
—
1d
-0.7%
3d
+0.9%
7d
+1.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS